Literature DB >> 10068447

The active site of phosphorylating glyceraldehyde-3-phosphate dehydrogenase is not designed to increase the nucleophilicity of a serine residue.

S Boschi-Muller1, G Branlant.   

Abstract

Changing a catalytic cysteine into a serine, and vice versa, generally leads to a dramatic decrease in enzymatic efficiency. Except a study done on thiol subtilisin, no extensive study was carried out for determining whether the decrease in activity is due to a low nucleophilicity of the introduced amino acid. In the present study, Cys149 of glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus was converted into a Ser residue. This leads to a drastic reduction of the kcat value. The rate-limiting step occurs before the hydride transfer step. Selective, but slow, inactivation is observed with specific, structurally different, inhibitors of serine protease. The esterolytic activity of serine mutant towards activated esters is also strongly decreased. The rate-limiting step of the esterase reaction also shifts from deacylation in the wild type to acylation in the mutant. Altogether, these results strongly suggest that the low catalytic efficiency of the Ser mutant is due to a poor nucleophilicity of the hydroxyl serine group within the active site of the enzyme. The fact that (1) the apo --> holo transition does not change esterolytic and inactivating efficiencies, and (2) Ser149 Asn176 double mutant exhibits the same chemical reactivity and esterolytic catalytic efficiency compared to the Ser149 single mutant indicates that the serine residue is not subject to His176 general base catalysis. A linear relationship between the catalytic dehydrogenase rate, the kcat/KM for esterolysis, and the concentration of OH- is observed, thus supporting the alcoholate entity as the attacking reactive species. Collectively this study shows that the active site environment of GAPDH is not adapted to increase the nucleophilicity of a serine residue. This is discussed in relation to what is known about Ser and Cys protease active sites. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068447     DOI: 10.1006/abbi.1998.1080

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Purification, crystallization and preliminary X-ray analysis of apo glyceraldehyde-3-phosphate dehydrogenase 1 (GAP1) from methicillin-resistant Staphylococcus aureus (MRSA252).

Authors:  Somnath Mukherjee; Baisakhee Saha; Debajyoti Dutta; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-29

2.  Expression, purification, crystallization and preliminary X-ray diffraction studies of glyceraldehyde-3-phosphate dehydrogenase 1 from methicillin-resistant Staphylococcus aureus (MRSA252).

Authors:  Somnath Mukherjee; Debajyoti Dutta; Baisakhee Saha; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-09-30

3.  Cloning, overexpression, purification, crystallization and preliminary X-ray diffraction analysis of glyceraldehyde-3-phosphate dehydrogenase from Antheraea mylitta.

Authors:  Somnath Mukherjee; Samita Maity; Sobhan Roy; Suvankar Ghorai; Mrinmay Chakrabarti; Rachit Agarwal; Debajyoti Dutta; Ananta Kumar Ghosh; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-08-26

Review 4.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.

Authors:  D Allan Butterfield; Sarita S Hardas; Miranda L Bader Lange
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Minimal genome encoding proteins with constrained amino acid repertoire.

Authors:  Olga Tsoy; Marina Yurieva; Andrey Kucharavy; Mary O'Reilly; Arcady Mushegian
Journal:  Nucleic Acids Res       Date:  2013-07-19       Impact factor: 16.971

6.  Epitopes identified in GAPDH from Clostridium difficile recognized as common antigens with potential autoimmunizing properties.

Authors:  Agnieszka Razim; Katarzyna Pacyga; Małgorzata Aptekorz; Gayane Martirosian; Andrzej Szuba; Edyta Pawlak-Adamska; Monika Brzychczy-Włoch; Andrzej Myc; Andrzej Gamian; Sabina Górska
Journal:  Sci Rep       Date:  2018-09-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.